Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Oxytocin receptor (OXTR) is a member of the Class A (rhodopsin-like) G protein-coupled receptor family that mediates the physiological effects of the neuropeptide oxytocin [1, 2, 6]. It is primarily known for its critical roles in female reproduction, where it triggers uterine contractions during labor and stimulates milk ejection from the mammary glands during lactation [1, 13]. In the central nervous system, OXTR is widely expressed in regions such as the amygdala and hypothalamus, where it modulates complex social and emotional behaviors, including pair bonding, maternal care, trust, and anxiety [6, 16]. Clinically, OXTR is a major therapeutic target; agonists like synthetic oxytocin are used to induce labor and prevent postpartum hemorrhage, while antagonists like atosiban are employed to manage preterm labor [13, 14]. Beyond obstetrics, the receptor is being investigated for its involvement in neuropsychiatric disorders like autism and social anxiety, as well as its potential role as a biomarker and therapeutic target in certain cancers [3, 7, 16].
Agonist, Antagonist
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxytocin receptor (OXTR) (OXTR).